Government to establish pricing criteria for efficacy-improved drugs

When an efficacy-improved drug gets listed for insurance coverage, the corresponding drug price will be determined in the same scope of the original drug whose patent was expired, the Ministry of Health and Welfare said recently.

The efficacy-improved drug refers to a drug whose chemical structure and/or formulation has been modified without infringing the patent of original drug.

The min...